VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 185 filers reported holding VIKING THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,491 | -11.2% | 225 | +30.1% | 0.00% | – |
| Q2 2023 | $2,804 | -2.6% | 173 | 0.0% | 0.00% | – |
| Q1 2023 | $2,880 | -91.8% | 173 | -97.7% | 0.00% | -100.0% |
| Q4 2021 | $35,000 | +775.0% | 7,500 | +1062.8% | 0.01% | +400.0% |
| Q3 2021 | $4,000 | 0.0% | 645 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $4,000 | 0.0% | 645 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $4,000 | -20.0% | 645 | -20.3% | 0.00% | 0.0% |
| Q4 2020 | $5,000 | +25.0% | 809 | +25.4% | 0.00% | 0.0% |
| Q3 2020 | $4,000 | -20.0% | 645 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $5,000 | +66.7% | 645 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $3,000 | -40.0% | 645 | 0.0% | 0.00% | -50.0% |
| Q4 2019 | $5,000 | +25.0% | 645 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $4,000 | -69.2% | 645 | -53.9% | 0.00% | -60.0% |
| Q1 2019 | $13,000 | -63.9% | 1,400 | -70.8% | 0.01% | -72.2% |
| Q4 2018 | $36,000 | – | 4,800 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 450,900 | $2,624,000 | 0.85% |
| Sio Capital Management, LLC | 709,780 | $4,131,000 | 0.82% |
| KNOTT DAVID M | 218,102 | $1,269,000 | 0.74% |
| ArrowMark Colorado Holdings LLC | 7,988,635 | $46,494,000 | 0.44% |
| Park West Asset Management LLC | 1,457,507 | $8,483,000 | 0.33% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 1,657 | $10,000 | 0.18% |
| Virtus ETF Advisers LLC | 42,507 | $247,000 | 0.13% |
| Cornerstone Capital, Inc. | 125,465 | $730,000 | 0.10% |
| L & S Advisors Inc | 114,988 | $669,000 | 0.09% |
| EXANE DERIVATIVES | 44,877 | $261,170,000 | 0.08% |